Sarcopenia threat?

Posted on September 29th, by geoff in CT blog. 2 comments

By Caring Times editor-in-chief Dr Richard Hawkins

Sarcopenia is the latest serious illness to be landed on the care home sector. A recent report in Age and Ageing said that 1 in 20 care home residents were likely to suffer from this previously never- heard- of condition. What then is sarcopenia? It is what you and I used to know as muscle weakness or frailty. Now however it has a grand name and we are warned that this serious illness might be associated with falls and even increased death. I am sure we are meant to be impressed.

It is, though, simply the latest in a trend towards giving fancy names to everyday conditions previously thought to be beyond the help of medical help but which are now treatable, thanks to some new and usually expensive treatment. The pharmaceutical industry has been active in discovering these new ‘illnesses’. So, sadness is rebranded as depression and of course requires active treatment with expensive anti-depressives. Shyness is branded as social phobia, and childhood naughtiness as hyperactivity or ADHD. A loss of interest in sex in men is called andropause and treated with the male hormone testosterone, and even women with similar sex disinterest are diagnosed as being ill and needing testosterone.

Big Pharma comes up with profitable new drugs to treat these ‘disorders’, drugs which psychiatrists and then GPs prescribe, sometimes richly rewarded by the pharma companies for doing so. In the last decade the use of such drugs has rocketed. By 2012 50 million prescriptions had been written for antidepressants alone.

Meanwhile the real underlying causes of behavioural problems and human misery are often left untreated. In the case of sarcopenia no pharmaceutical company is involved. However, the authors do say that treatment is at hand. They recommend exercise – no harm there, we have been doing that for years. But they also recommend short term nutritional intervention trials using proteins, essential amino acids, leucine or beta-hydroxy beta-methylbutyrate although they acknowledge that that evidence from longer-term trials is sparse. Unquestionably some nutritional supplements companies are going to benefit from this advice. And care home owners will undoubtedly be under pressure to initiate a treatment for this serious new condition, sarcopenia – remember you heard it here first.

  • The CT Blog is written in a personal capacity – comments and opinions expressed are not necessarily endorsed or supported by Caring Times.

2 responses to “Sarcopenia threat?”

  1. Gillian Dalley says:

    Very valid points. I’m going to keep my eyes open for the first reference to it.

  2. Bob Ferguson says:

    It’s a great pity that you have devalued what would otherwise be a telling argument by putting – or appearing to put – clinical depression in the same bracket as “sadness”. Presumably your preferred treatment would be a sharp exhortation to “snap out of it”. Any sufferers reading your blog will be more than “sad”.

Latest blog posts

The NHS and all that jazz

By Caring Times editor GEOFF HODGSON

Last week the National Health Service marked its 70th anniversary. The irony is that, when this all too human institution...

The bland leaving the bland?

By guest blogger JEF SMITH

The headline for an interview which Sir David Behan, the Care Quality Commission’s departing chief executive, gave to The Guardian...

IT comes to CQC

By guest blogger JOHN BURTON

This month, IT is coming to CQC in person. David Behan is leaving, and DB’s replacement is IT, Ian Trenholm...